OBJECTIVE: Large-scale prospective studies do not support an association between neuroticism and extroversion with cancer incidence. However, research on other personality constructs is inconclusive. This longitudinal study examined the associations between four personality measures, Type 1, "suppressed emotional expression"; Type 5, "rational/antiemotional"; hostility; and Type A with cancer incidence. METHODS: Personality measures were available for 13,768 members in the GAZEL cohort study (baseline assessment in 1993). Follow-up for diagnoses of primary cancers was obtained from January 1, 1994 to December 31, 2009. Associations between personality and cancer incidence were evaluated using Cox proportional hazards analyses and adjusted for potential confounders. RESULTS: During a median follow-up of 16.0 years (range, 9 days-16 years), 1139 participants were diagnosed as having a primary cancer. The mean duration between baseline and cancer diagnosis was 9.3 years. Type 1 personality was associated with a decreased risk of breast cancer (hazard ratio per standard deviation = 0.81, 95% confidence interval = 0.68-0.97, p = .02). Type 5 personality was not associated with prostate, breast, colorectal, or smoking-related cancers, but was associated with other cancers (hazard ratio per standard deviation = 1.17, 95% confidence interval = 1.04-1.31, p = .01). Hostility was associated with an increased risk of smoking-related cancers, which was explained by smoking habits, and Type A was not associated with any of the cancer endpoints. CONCLUSIONS: Several personality measures were prospectively associated with the incidence of selected cancers. These links may warrant further epidemiological studies and investigations about potential biobehavioral mechanisms.
OBJECTIVE: Large-scale prospective studies do not support an association between neuroticism and extroversion with cancer incidence. However, research on other personality constructs is inconclusive. This longitudinal study examined the associations between four personality measures, Type 1, "suppressed emotional expression"; Type 5, "rational/antiemotional"; hostility; and Type A with cancer incidence. METHODS: Personality measures were available for 13,768 members in the GAZEL cohort study (baseline assessment in 1993). Follow-up for diagnoses of primary cancers was obtained from January 1, 1994 to December 31, 2009. Associations between personality and cancer incidence were evaluated using Cox proportional hazards analyses and adjusted for potential confounders. RESULTS: During a median follow-up of 16.0 years (range, 9 days-16 years), 1139 participants were diagnosed as having a primary cancer. The mean duration between baseline and cancer diagnosis was 9.3 years. Type 1 personality was associated with a decreased risk of breast cancer (hazard ratio per standard deviation = 0.81, 95% confidence interval = 0.68-0.97, p = .02). Type 5 personality was not associated with prostate, breast, colorectal, or smoking-related cancers, but was associated with other cancers (hazard ratio per standard deviation = 1.17, 95% confidence interval = 1.04-1.31, p = .01). Hostility was associated with an increased risk of smoking-related cancers, which was explained by smoking habits, and Type A was not associated with any of the cancer endpoints. CONCLUSIONS: Several personality measures were prospectively associated with the incidence of selected cancers. These links may warrant further epidemiological studies and investigations about potential biobehavioral mechanisms.
Authors: O Todarello; A Casamassima; S Daniele; M Marinaccio; F Fanciullo; L Valentino; N Tedesco; S Wiesel; G Simone; L Marinaccio Journal: Psychother Psychosom Date: 1997 Impact factor: 17.659
Authors: O Todarello; A Casamassima; M Marinaccio; M W La Pesa; L Caradonna; L Valentino; L Marinaccio Journal: Psychother Psychosom Date: 1994 Impact factor: 17.659
Authors: A Chevalier; M Goldberg; C Godard; P Guénel; B Callet; B Antonini; A Medard; F Coing Journal: Rev Epidemiol Sante Publique Date: 1996-01 Impact factor: 1.019
Authors: Elizabeth M Poole; Laura D Kubzansky; Anil K Sood; Olivia I Okereke; Shelley S Tworoger Journal: Cancer Causes Control Date: 2016-03-29 Impact factor: 2.506
Authors: Cédric Lemogne; Monica Turinici; Henri Panjo; Charlotte Ngo; Florence Canoui-Poitrine; Jean-Christophe Chauvet-Gelinier; Frédéric Limosin; Silla M Consoli; Marcel Goldberg; Marie Zins; Virginie Ringa Journal: Cancer Med Date: 2017-12-26 Impact factor: 4.452
Authors: Ciro Conversano; Mariagrazia Di Giuseppe; Mario Miccoli; Rebecca Ciacchini; Annarita Di Silvestre; Rosa Lo Sterzo; Angelo Gemignani; Graziella Orrù Journal: Clin Neuropsychiatry Date: 2020-08
Authors: Claire L Niedzwiedz; Kathryn A Robb; Srinivasa Vittal Katikireddi; Jill P Pell; Daniel J Smith Journal: Psychooncology Date: 2019-11-19 Impact factor: 3.955